A. R. Peregonchiy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
A. R. Peregonchiy has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- O. B. Pavlenko
All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy
7 shared publications - Vitaliy I. Zimnikov
All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy
5 shared publications - I. V. Bryukhova
All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy
2 shared publications - Liliya V. Cheskidova
All-Russian Research Veterinary Institute of Pathology, Pharmacology and Therapy
2 shared publications - G.N. Bliznetsova1 shared publication
- Larisa Yu. Sashnina
All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy
1 shared publication
Latest Publications
- Open Access
- 26 January 2024
- Published by Saint-Petersburg State University of Veterinary Medicine in Legal regulation in veterinary medicine
- No. 4,p. 124-128
Study of acute toxity and wound healing effect of the complex ointment «Uberosept»
The design of drugs that allow the unlimited use of animal products is an important area of veterinary pharmacology. In this regard, in the production of a new complex ointment intended for treating the skin of the udder of cows, natural components were selected. The formula for “Uberosept” ointment includes ichthyol, pine resin and camphor. One of the important stages of preclinical study of new drugs is to identify their toxic properties and evaluate their efficacy. Therefore, the purpose of our work was to determine the toxicity class and study the wound-healing effect of “Uberosept”. The acute toxicity of “Uberosept” ointment was tested during intragastric administration using a fixed dose method (GOST 32296-2013) on female white mice. The wound healing effect was studied in a full-thickness skin wound model in female rats. It has been established that “Uberosept” ointment can be classified as hazard class 5. When administered intragastrically at a maximum dose of 5000 mg/kg during the first 30 minutes and the next 14 days, no signs of intoxication were detected in all experimental mice.
- 26 January 2024
- Published by Saint-Petersburg State University of Veterinary Medicine in Legal regulation in veterinary medicine
- No. 4,p. 124-128
Open AccessStudy of acute toxity and wound healing effect of the complex ointment «Uberosept»
The design of drugs that allow the unlimited use of animal products is an important area of veterinary pharmacology. In this regard, in the production of a new complex ointment intended for treating the skin of the udder of cows, natural components were selected. The formula for “Uberosept” ointment includes ichthyol, pine resin and camphor. One of the important stages of preclinical study of new drugs is to identify their toxic properties and evaluate their efficacy. Therefore, the purpose of our work was to determine the toxicity class and study the wound-healing effect of “Uberosept”. The acute toxicity of “Uberosept” ointment was tested during intragastric administration using a fixed dose method (GOST 32296-2013) on female white mice. The wound healing effect was studied in a full-thickness skin wound model in female rats. It has been established that “Uberosept” ointment can be classified as hazard class 5. When administered intragastrically at a maximum dose of 5000 mg/kg during the first 30 minutes and the next 14 days, no signs of intoxication were detected in all experimental mice.
- Open Access
- 24 January 2024
- Published by Saint-Petersburg State University of Veterinary Medicine in Legal regulation in veterinary medicine
- No. 4,p. 84-90
Morphobiochemical status of cows’ blood during therapy of subclinical mastitis with the complex ointment "Uberosept" together with immunomodulators
The studies were conducted on lactating cows of Red-Motley Holstein and Simmental breeds with subclinical mastitis aged from 1 to 8 lactations. Four groups of animals of 10 animals each were selected. The first group was treated with the complex ointment “Uberosept” once a day, externally for 5 days. The second group received “Uberosept” 1 time per day, externally for 5 days, “Mixoferon” 3 ml intramuscularly 2 times a day for 7 days. The third group received “Uberosept” 1 time per day, externally for 5 days, “Submastin-KRS” 10 ml intramuscularly 1 time per day for 3 days. Blood samples were taken from all experimental groups to study morphobiochemical indicators and indicators of lipid peroxidation, antioxidant protection and endogenous intoxication. The samples were taken before treatment, immediately after the course of treatment and 7 days after treatment. The highest therapeutic effectiveness of the treatment regimen for subclinical mastitis used in the second experimental group was 90.0%. In the first experimental group, the therapeutic effectiveness was 60.0%, in the second experimental group - 80.0%. This was confirmed by morphobiochemical studies; in the group of animals that were injected with “Mixoferon” + complex ointment “Uberosept”, immunity indicators were higher than in the group of cows that were treated with “Submastin-KRS” + complex ointment “Uberosept”. At the same time, in the animals of the third experimental group, a more pronounced decrease in the processes of endogenous intoxication, lipid peroxidation and activation of antioxidant protection was observed.
- 24 January 2024
- Published by Saint-Petersburg State University of Veterinary Medicine in Legal regulation in veterinary medicine
- No. 4,p. 84-90
Open AccessMorphobiochemical status of cows’ blood during therapy of subclinical mastitis with the complex ointment "Uberosept" together with immunomodulators
The studies were conducted on lactating cows of Red-Motley Holstein and Simmental breeds with subclinical mastitis aged from 1 to 8 lactations. Four groups of animals of 10 animals each were selected. The first group was treated with the complex ointment “Uberosept” once a day, externally for 5 days. The second group received “Uberosept” 1 time per day, externally for 5 days, “Mixoferon” 3 ml intramuscularly 2 times a day for 7 days. The third group received “Uberosept” 1 time per day, externally for 5 days, “Submastin-KRS” 10 ml intramuscularly 1 time per day for 3 days. Blood samples were taken from all experimental groups to study morphobiochemical indicators and indicators of lipid peroxidation, antioxidant protection and endogenous intoxication. The samples were taken before treatment, immediately after the course of treatment and 7 days after treatment. The highest therapeutic effectiveness of the treatment regimen for subclinical mastitis used in the second experimental group was 90.0%. In the first experimental group, the therapeutic effectiveness was 60.0%, in the second experimental group - 80.0%. This was confirmed by morphobiochemical studies; in the group of animals that were injected with “Mixoferon” + complex ointment “Uberosept”, immunity indicators were higher than in the group of cows that were treated with “Submastin-KRS” + complex ointment “Uberosept”. At the same time, in the animals of the third experimental group, a more pronounced decrease in the processes of endogenous intoxication, lipid peroxidation and activation of antioxidant protection was observed.
- Open Access
- 1 January 2024
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 60 (4)
STUDY OF THE IRRITANT EFFECT AND ANTI-INFLAMMATORY ACTIVITY OF THE OINTMENT UBEROSEPT
The article presents the results of two series of experiments on studying the local irritant and anti-inflammatory action of a new complex ointment Uberosept. The studies of the anti-inflammatory activity of the drug were carried out on white rats using the zymosan-induced paw edema model. It has been found that the Uberosept ointment possesses pronounced anti-inflammatory properties, that are not inferior to the comparison drug (Hydrocortisone ointment). The experiments to assess the irritant effect of Uberosept were conducted on guinea pigs. The animals were applied the complex ointment at doses of 0.12 and 0.6 g to the skin used as a single dose, and at a dose of 0.12 g for 14 days. Based on the conducted studies, it can be concluded that the ointment Uberosept does not cause an irritant effect on the skin with a single or long-term use.
- 1 January 2024
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 60 (4)
Open AccessSTUDY OF THE IRRITANT EFFECT AND ANTI-INFLAMMATORY ACTIVITY OF THE OINTMENT UBEROSEPT
The article presents the results of two series of experiments on studying the local irritant and anti-inflammatory action of a new complex ointment Uberosept. The studies of the anti-inflammatory activity of the drug were carried out on white rats using the zymosan-induced paw edema model. It has been found that the Uberosept ointment possesses pronounced anti-inflammatory properties, that are not inferior to the comparison drug (Hydrocortisone ointment). The experiments to assess the irritant effect of Uberosept were conducted on guinea pigs. The animals were applied the complex ointment at doses of 0.12 and 0.6 g to the skin used as a single dose, and at a dose of 0.12 g for 14 days. Based on the conducted studies, it can be concluded that the ointment Uberosept does not cause an irritant effect on the skin with a single or long-term use.
- 1 January 2024
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 60
STUDY OF THE THERAPEUTIC EFFICACY OF A COMPLEX TREATMENT REGIMEN FOR BOVINE SUBCLINICAL MASTITIS
The article presents the material on the study of the clinical efficacy of a complex treatment regimen for bovine subclinical mastitis with the interferon-containing drug Mixoferon in combination with the complex ointment Uberosept. This complex treatment regimen for bovine subclinical mastitis, including intramuscular administration of Mixoferon at a dose of 3.0 ml 2 times a day for 7 days and applying the ointment Uberosept at a dose of 3.0 g once a day for 5 days on the affected quarter of the udder, provided a therapeutic efficacy of 80.0-83.3%. And the greater therapeutic efficacy is also confirmed by the somatic cells count test for the mammary gland secretion. After the treatment course in both experimental groups, the content of somatic cells decreased by 63.6% and 54.2%, respectively.
- 1 January 2024
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 60
STUDY OF THE THERAPEUTIC EFFICACY OF A COMPLEX TREATMENT REGIMEN FOR BOVINE SUBCLINICAL MASTITIS
The article presents the material on the study of the clinical efficacy of a complex treatment regimen for bovine subclinical mastitis with the interferon-containing drug Mixoferon in combination with the complex ointment Uberosept. This complex treatment regimen for bovine subclinical mastitis, including intramuscular administration of Mixoferon at a dose of 3.0 ml 2 times a day for 7 days and applying the ointment Uberosept at a dose of 3.0 g once a day for 5 days on the affected quarter of the udder, provided a therapeutic efficacy of 80.0-83.3%. And the greater therapeutic efficacy is also confirmed by the somatic cells count test for the mammary gland secretion. After the treatment course in both experimental groups, the content of somatic cells decreased by 63.6% and 54.2%, respectively.
- Open Access
- 1 January 2024
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 60 (2)
IMMUNE STATUS OF COWS IN CASE OF SUBCLINICAL MASTITIS TREATMENT WITH UBEROSEPT AND INTERFERON-CONTAINING DRUGS
The article presents a comparative analysis of immunity indicators in the lactating cows with subclinical mastitis, after treatment with the ointment Uberosept and in combination with the drugs containing interferons. It has been found that treatment regimens using the immunomodulatory drugs Submastin KRS and Mixoferon lead to an increase in the serum bactericidal and lysozyme activity. The number of total immunoglobulins increased significantly. Moreover, after the course of treatment, a decrease in the number of circulating immune complexes was noted, which indicated a decrease in the antigenic load and partial release from microorganisms that cause mastitis. In experimental groups No. 2 and No. 3, there was a tendency towards a decrease in phagocytic activity, phagocytic index and phagocytic number, which indicated the stage of recovery. When comparing two treatment regimens with interferoncontaining drugs, it was noted that in the experimental group in which “Mixoferon” was used, a more pronounced immunostimulating effect was observed.
- 1 January 2024
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 60 (2)
Open AccessIMMUNE STATUS OF COWS IN CASE OF SUBCLINICAL MASTITIS TREATMENT WITH UBEROSEPT AND INTERFERON-CONTAINING DRUGS
The article presents a comparative analysis of immunity indicators in the lactating cows with subclinical mastitis, after treatment with the ointment Uberosept and in combination with the drugs containing interferons. It has been found that treatment regimens using the immunomodulatory drugs Submastin KRS and Mixoferon lead to an increase in the serum bactericidal and lysozyme activity. The number of total immunoglobulins increased significantly. Moreover, after the course of treatment, a decrease in the number of circulating immune complexes was noted, which indicated a decrease in the antigenic load and partial release from microorganisms that cause mastitis. In experimental groups No. 2 and No. 3, there was a tendency towards a decrease in phagocytic activity, phagocytic index and phagocytic number, which indicated the stage of recovery. When comparing two treatment regimens with interferoncontaining drugs, it was noted that in the experimental group in which “Mixoferon” was used, a more pronounced immunostimulating effect was observed.
- Open Access
- 1 January 2023
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 59 (3)
CLINICAL EFFICACY OF THE COMPLEX OINTMENT FOR TREATMENT SUBCLINICAL MASTITIS IN COWS
- 1 January 2023
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 59 (3)
Open AccessCLINICAL EFFICACY OF THE COMPLEX OINTMENT FOR TREATMENT SUBCLINICAL MASTITIS IN COWS
- Open Access
- 1 January 2023
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 59 (4)
STUDIES ON THE SAFETY OF THE COMPLEX OINTMENT UBEROSEPT
ФГБНУ «Всероссийский научно-исследовательский ветеринарный институт патологии, фармакологии и терапии», г. Воронеж, Российская Федерация В статье приведены данные по исследованию безвредности комплексной мази «Уберосепт». После нанесения мази на долю вымени в терапевтической дозе 5,0 г и трехкратно ее превышающей-15,0 г не наблюдали изменений в клиническом состоянии животного, а именно пульс, температура тела, количество дыхательных движений. Также не отмечено изменений в показателях среднесуточной молочной продуктивности за исследуемый период. При анализе морфологического состава крови, гематологических показателей (лейкоциты, эритроциты гемоглобин, гематокрит, СОЭ) не было установлено изменений, говорящих о негативном влиянии мази «Уберосепт» на организм. Биохимический анализ крови не установил патогенного воздействия препарата на какую-либо систему органов. Показатели белкового, углеводного, липидного и минерального обмена не претерпели каких-либо значительных изменений. Трансдермальный
- 1 January 2023
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 59 (4)
Open AccessSTUDIES ON THE SAFETY OF THE COMPLEX OINTMENT UBEROSEPT
ФГБНУ «Всероссийский научно-исследовательский ветеринарный институт патологии, фармакологии и терапии», г. Воронеж, Российская Федерация В статье приведены данные по исследованию безвредности комплексной мази «Уберосепт». После нанесения мази на долю вымени в терапевтической дозе 5,0 г и трехкратно ее превышающей-15,0 г не наблюдали изменений в клиническом состоянии животного, а именно пульс, температура тела, количество дыхательных движений. Также не отмечено изменений в показателях среднесуточной молочной продуктивности за исследуемый период. При анализе морфологического состава крови, гематологических показателей (лейкоциты, эритроциты гемоглобин, гематокрит, СОЭ) не было установлено изменений, говорящих о негативном влиянии мази «Уберосепт» на организм. Биохимический анализ крови не установил патогенного воздействия препарата на какую-либо систему органов. Показатели белкового, углеводного, липидного и минерального обмена не претерпели каких-либо значительных изменений. Трансдермальный